$EIGR Eiger BioPharmaceuticals, Inc. Insider Trading Week 11/2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Eiger BioPharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Eiger BioPharmaceuticals, Inc. in week 11/2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Option Exercise | A | 9.99 | 71,250 | 711,788 | 71,250 | |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Shaffer James P | Chief Business Offi ... | Grant | A | 0.00 | 11,875 | 0 | 29,296 | 17.4 K to 29.3 K (+68.16 %) |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Sachdev Amit | Director | Option Exercise | A | 9.99 | 10,000 | 99,900 | 10,000 | |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Sachdev Amit | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Ryali Sriram | Chief Financial Off ... | Option Exercise | A | 9.99 | 97,500 | 974,025 | 97,500 | |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Ryali Sriram | Chief Financial Off ... | Grant | A | 0.00 | 16,250 | 0 | 18,152 | 1.9 K to 18.2 K (+854.36 %) |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Patton Stephana Eilene | See Remarks | Option Exercise | A | 9.99 | 71,250 | 711,788 | 71,250 | |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Patton Stephana Eilene | See Remarks | Grant | A | 0.00 | 11,875 | 0 | 17,948 | 6.1 K to 17.9 K (+195.54 %) |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Murray Christine | Director | Option Exercise | A | 9.99 | 10,000 | 99,900 | 10,000 | |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Murray Christine | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Mayer Eldon C. III | Ex VP & Chief Comme ... | Option Exercise | A | 9.99 | 71,250 | 711,788 | 71,250 | |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Mayer Eldon C. III | Ex VP & Chief Comme ... | Grant | A | 0.00 | 11,875 | 0 | 47,685 | 35.8 K to 47.7 K (+33.16 %) |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Loh Evan | Director | Option Exercise | A | 9.99 | 10,000 | 99,900 | 10,000 | |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Loh Evan | Director | Sell | S | 10.14 | 2,000 | 20,280 | 8,000 | 10 K to 8 K (-20.00 %) |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Loh Evan | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Glenn Jeffrey S | Director | Option Exercise | A | 9.99 | 10,000 | 99,900 | 10,000 | |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Glenn Jeffrey S | Director | Grant | A | 0.00 | 5,000 | 0 | 76,355 | 71.4 K to 76.4 K (+7.01 %) |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Option Exercise | A | 9.99 | 20,000 | 199,800 | 20,000 | |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Dietz Thomas John | Director | Grant | A | 0.00 | 5,000 | 0 | 35,000 | 30 K to 35 K (+16.67 %) |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Option Exercise | A | 9.99 | 281,000 | 2,807,190 | 281,000 | |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Cory David A | President and CEO | Grant | A | 0.00 | 47,000 | 0 | 117,846 | 70.8 K to 117.8 K (+66.34 %) |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Apelian David | Director | Option Exercise | A | 9.99 | 10,000 | 99,900 | 10,000 | |
Mar 15 2021 | EIGR | Eiger BioPharmaceu ... | Apelian David | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |